First pulmonary embolism patient enrolled in FLAME study

Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study. One in 20 PE diagnoses is categorized as high risk, and these are associated with a…
When there are none: Why manels are out

On June 12, 2019, the director of the National Institutes of Health, Francis Collins, MD, made a public commitment to decline to take part in panels that “do not fairly evaluate scientists of all backgrounds for speaking opportunities.”1 Collins referred…
‘More robust’ studies needed to confirm near infrared spectroscopy as valuable tool in lower extremity arterial disease patients

“The available data suggest that exercise training improves de-oxygenation and re-oxygenation patterns, as measured with near infrared spectroscopy (NIRS), in patients with lower extremity arterial disease (LEAD),” conclude Nils Cornelis, PhD, of KU Leuven in Leuven, Belgium, and colleagues in…
Surmodics announces first patient uses of two Sublime radial access platform devices

Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath and Sublime radial access .014 RX percutaneous transluminal angioplasty (PTA) dilatation catheter. Constantino Pena, MD, Andrew Niekamp,…
US surgeons begin commercial use of Gore Excluder conformable AAA endoprosthesis with Active Control system

W. L. Gore & Associates (Gore) today announced the first use of the Food and Drug Administration (FDA)-approved Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprothesis with Active Control system in cases outside of clinical trials. Cases were successfully performed…
APDVS honors Jack L. Cronenwett with inaugural Lifetime Achievement in Education Award

The Association of Program Directors in Vascular Surgery (APDVS) bestowed its first-ever Lifetime Achievement in Education Award on the association’s one-time president Jack L. Cronenwett, MD, during its annual Spring Meeting (March 26–27) today. Making the presentation, APDVS immediate past…
Details emerge on VRIC’s move to VAM 2021

In celebration of the 75th year of the SVS, the Vascular Research Initiatives Conference (VRIC), typically held in early May, is moving this year to be held during the 2021 VAM in August. In a year when so much has…
Researchers recommend national registries address geographical variation in DVT guideline implementation

A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from strict adherence to no adherence at all. “In this content,” suggest authors Carla Rognoni, PhD, of SDA…
‘A reliable tool’: Positive findings for 2D perfusion angiography in CLTI patients

Researchers suggest that in patients with chronic limb-threatening ischemia (CLTI), two-dimensional (2D) perfusion angiography is a “reliable tool” when used according to standardized methods. Jetty Ipema, PhD, of St Antonius Hospital, Nieuwegein, The Netherlands, and colleagues write in the European Journal…
‘Highly implementable’ price sheet strategy sparks cost reduction in vascular procedures

A simple cost reduction strategy implemented among providers in an academic vascular surgery practice yielded data demonstrating sometimes significant cost savings—in the case of common femoral endarterectomy of nearly 70%. The researchers behind the study found significant savings made across…

